An investor in NYSE:XON shares filed a lawsuitover alleged violations of Federal Securities Laws by Intrexon Corp in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Intrexon Corp (NYSE:XON) have certain options and for certain investors are short and strict deadlines running. Deadline: July 5, 2016. NYSE:XON investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The plaintiff alleges on behalf of purchasers of Intrexon Corp (NYSE:XON) common shares between May 12, 2015 and April 20, 2016, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 12, 2015 and April 20, 2016 the defendants issued false and misleading financial statements to investors.
On April 21, 2016, a report was published on Intrexon Corp asserting, among other things, that Intrexon’s technology has recently been questioned by high-ranking officials from the WHO, CDC and NIH, that Intrexon overstated revenues by 50% through transactions with related parties, thatIntrexon’s technology platform is an overhyped, undifferentiated collection of commodity and failed products, and that Intrexon is the Theranos of the public markets.
Shares of Intrexon Corp (NYSE:XON) closed on May 13, 2016 at $
per share.
Those who purchased NYSE:XON shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com